HCA Healthcare, Inc. (NYSE:HCA) Stock Holdings Lifted by Vinva Investment Management Ltd

Vinva Investment Management Ltd increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 15.9% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 9,457 shares of the company’s stock after acquiring an additional 1,298 shares during the period. Vinva Investment Management Ltd’s holdings in HCA Healthcare were worth $3,814,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the stock. Terra Nova Asset Management LLC increased its holdings in shares of HCA Healthcare by 0.3% during the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after acquiring an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV grew its holdings in HCA Healthcare by 7.4% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after buying an additional 29 shares during the last quarter. Waldron Private Wealth LLC grew its holdings in HCA Healthcare by 1.8% in the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after buying an additional 29 shares during the last quarter. Brookstone Capital Management grew its holdings in HCA Healthcare by 0.7% in the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after buying an additional 30 shares during the last quarter. Finally, UMB Bank n.a. grew its holdings in HCA Healthcare by 2.4% in the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after buying an additional 30 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,155 shares of company stock valued at $5,608,990. Company insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on HCA shares. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. UBS Group raised their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price objective for the stock from $400.00 to $320.00 in a research report on Monday. Barclays reduced their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research report on Friday, November 8th. Finally, Oppenheimer raised their price objective on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. One research analyst has rated the stock with a sell rating, five have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $380.29.

HCA Healthcare Trading Down 1.1 %

Shares of HCA opened at $325.47 on Friday. The stock has a fifty day moving average price of $373.42 and a two-hundred day moving average price of $358.28. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare, Inc. has a 52-week low of $245.84 and a 52-week high of $417.14. The company has a market cap of $82.44 billion, a price-to-earnings ratio of 14.61, a PEG ratio of 1.25 and a beta of 1.68.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.81%. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.